Cancer Vaccine Institute News

On the Cancer Research Frontier is a series spotlighting the scientists, doctors, nurses, patients, and philanthropists at the Cancer Vaccine Institute. Join us in meeting the brilliant minds behind our cancer vaccines and immunotherapies as they share their professional journeys and personal stories. On the dance floor, Meera Suresh moves her body rhythmically to the lively percussion, her facial expressions sharp and focused. Her arms move in angular patterns to the beat wh

On the Cancer Research Frontier is a series spotlighting the scientists, doctors, nurses, patients, and philanthropists at the Cancer Vaccine Institute. Join us in meeting the brilliant minds behind our cancer vaccines and immunotherapies as they share their professional journeys and personal stories. For 17 years, Doreen Higgins was often one of the first people participants met when considering a Cancer Vaccine Institute (CVI) clinical trial. Before they made the decision

The first half of 2026 has been an exciting one at the Cancer Vaccine Institute (CVI), and we are proud to share the progress we’ve made in our Midyear Review. We have six clinical trials actively recruiting, with four additional studies opening soon. Our faculty and research teams have been recognized through competitive awards, invited presentations, and impactful scientific publications. These achievements highlight the significance of our work and elevate the visibility o

Photo Credits: Lisa Stromme Warren The Cancer Vaccine Institute is proud to celebrate Dr. Nora Disis, CVI Director, on her selection as a 2026 Fellow of the Academy of Immuno-Oncology by the Society for Immunotherapy of Cancer (SITC). This distinction honors scientific leaders whose work has made significant contributions to the field of cancer immunotherapy. Dr. Disis joins a distinguished class of scientific leaders who have made contributions that have shaped cancer immuno

Dr. Nora Disis, Director of the Cancer Vaccine Institute (CVI), recently joined Dr. Katherine Glass, host of the European Medical Journal’s (EMJ) Onc Now podcast, to discuss the evolving field of cancer vaccines and the future of immunotherapy.